Hereditary Transthyretin Amyloidosis Polyneuropathy.

In the last decade, we have witnessed dramatic improvements in the diagnosis, workup, management, and monitoring of patients with hereditary transthyretin amyloidosis (ATTRv). Updated imaging techniques (e.g.,

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

Chafic Karam has served as consultant and/or advisory board for Acceleron: Alpine, Alexion, Alnylam, Annexon, Argenx, Astra Zeneca, Corino, Biogen, CSL Behring, Genentech, Ionis, Neuroderm, Novo Nordisk, Octapharma, Pfizer, Sanofi, UCB, Takeda, and Zai lab. He has received research funding from Argenx, Astra Zeneca, Ionis and Genzyme.